Bioxodes SA, a clinical stage biopharmaceutical company developing novel therapies for the prevention and treatment of thrombotic and inflammatory diseases, has received Orphan Drug Designation (ODD) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback